Nordea Investment Management AB Sells 1,914 Shares of Chemed Corporation $CHE

Nordea Investment Management AB trimmed its holdings in shares of Chemed Corporation (NYSE:CHE) by 13.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,355 shares of the company’s stock after selling 1,914 shares during the period. Nordea Investment Management AB’s holdings in Chemed were worth $5,300,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. Smartleaf Asset Management LLC boosted its stake in Chemed by 71.4% in the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after purchasing an additional 25 shares in the last quarter. First Horizon Corp bought a new stake in shares of Chemed during the third quarter worth $31,000. Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of Chemed in the third quarter valued at $45,000. HM Payson & Co. increased its stake in shares of Chemed by 35.5% in the third quarter. HM Payson & Co. now owns 103 shares of the company’s stock valued at $46,000 after buying an additional 27 shares in the last quarter. Finally, Geneos Wealth Management Inc. raised its holdings in shares of Chemed by 330.4% in the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after buying an additional 76 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Thursday, March 12th. The shares were sold at an average price of $403.18, for a total transaction of $806,360.00. Following the completion of the sale, the chief executive officer owned 93,719 shares in the company, valued at $37,785,626.42. The trade was a 2.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 3.29% of the company’s stock.

Analysts Set New Price Targets

CHE has been the topic of several research reports. Jefferies Financial Group downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Oppenheimer lowered their price objective on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, February 27th. Zacks Research downgraded shares of Chemed from a “hold” rating to a “strong sell” rating in a research note on Wednesday, March 4th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Finally, Royal Bank Of Canada reissued a “sector perform” rating and set a $422.00 price target (down from $572.00) on shares of Chemed in a research note on Friday, February 27th. Two research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $498.00.

Chemed Stock Down 0.7%

CHE stock opened at $371.46 on Friday. Chemed Corporation has a twelve month low of $368.44 and a twelve month high of $623.60. The company has a market cap of $5.11 billion, a P/E ratio of 20.22, a PEG ratio of 1.48 and a beta of 0.46. The business has a fifty day moving average of $429.83 and a 200-day moving average of $436.19.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.02 by ($0.60). The firm had revenue of $639.34 million during the quarter, compared to the consensus estimate of $659.09 million. Chemed had a net margin of 10.48% and a return on equity of 25.66%. Chemed’s revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.83 EPS. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. As a group, equities research analysts anticipate that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were paid a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Monday, February 23rd. Chemed’s dividend payout ratio (DPR) is 13.06%.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.